Whit Mayo
Stock Analyst at Leerink Partners
(3.20)
# 1,060
Out of 5,245 analysts
157
Total ratings
53.92%
Success rate
10.54%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $345 → $400 | $388.47 | +2.97% | 13 | Apr 22, 2026 | |
| ARDT Ardent Health | Maintains: Outperform | $16 → $15 | $9.23 | +62.51% | 3 | Mar 6, 2026 | |
| CLOV Clover Health Investments | Maintains: Market Perform | $3 → $2.5 | $3.55 | -29.58% | 5 | Mar 5, 2026 | |
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $10.45 | +14.83% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $23.18 | -5.09% | 12 | Feb 26, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $173.78 | +51.92% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $21.26 | -20.04% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $394.69 | -21.46% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $5.33 | -53.10% | 5 | Mar 31, 2025 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $307.95 | -18.82% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $104.96 | -4.73% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $58.50 | -74.36% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $157.80 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $153.95 | -36.99% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $286.24 | +17.03% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $394.07 | -27.42% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $13.37 | +199.29% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $22.79 | +71.13% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $825 → $750 | $86.39 | +768.16% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $92.24 | +89.72% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $16.35 | +16.21% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.80 | +42.86% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $259.93 | -21.90% | 2 | May 1, 2018 |
UnitedHealth Group
Apr 22, 2026
Maintains: Outperform
Price Target: $345 → $400
Current: $388.47
Upside: +2.97%
Ardent Health
Mar 6, 2026
Maintains: Outperform
Price Target: $16 → $15
Current: $9.23
Upside: +62.51%
Clover Health Investments
Mar 5, 2026
Maintains: Market Perform
Price Target: $3 → $2.5
Current: $3.55
Upside: -29.58%
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $10.45
Upside: +14.83%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $23.18
Upside: -5.09%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $173.78
Upside: +51.92%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $21.26
Upside: -20.04%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $394.69
Upside: -21.46%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $5.33
Upside: -53.10%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $307.95
Upside: -18.82%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $104.96
Upside: -4.73%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $58.50
Upside: -74.36%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $157.80
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $153.95
Upside: -36.99%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $286.24
Upside: +17.03%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $394.07
Upside: -27.42%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $13.37
Upside: +199.29%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $22.79
Upside: +71.13%
Nov 4, 2022
Maintains: Outperform
Price Target: $825 → $750
Current: $86.39
Upside: +768.16%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $92.24
Upside: +89.72%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $16.35
Upside: +16.21%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.80
Upside: +42.86%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $259.93
Upside: -21.90%